IBDEI1L7 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26545,1,4,0)
 ;;=4^H02.831
 ;;^UTILITY(U,$J,358.3,26545,2)
 ;;=^5004418
 ;;^UTILITY(U,$J,358.3,26546,0)
 ;;=H02.832^^130^1292^15
 ;;^UTILITY(U,$J,358.3,26546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26546,1,3,0)
 ;;=3^Dermatochalasis,Right Lower Eyelid
 ;;^UTILITY(U,$J,358.3,26546,1,4,0)
 ;;=4^H02.832
 ;;^UTILITY(U,$J,358.3,26546,2)
 ;;=^5004419
 ;;^UTILITY(U,$J,358.3,26547,0)
 ;;=H02.834^^130^1292^14
 ;;^UTILITY(U,$J,358.3,26547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26547,1,3,0)
 ;;=3^Dermatochalasis,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,26547,1,4,0)
 ;;=4^H02.834
 ;;^UTILITY(U,$J,358.3,26547,2)
 ;;=^5004421
 ;;^UTILITY(U,$J,358.3,26548,0)
 ;;=H02.835^^130^1292^13
 ;;^UTILITY(U,$J,358.3,26548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26548,1,3,0)
 ;;=3^Dermatochalasis,Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,26548,1,4,0)
 ;;=4^H02.835
 ;;^UTILITY(U,$J,358.3,26548,2)
 ;;=^5133443
 ;;^UTILITY(U,$J,358.3,26549,0)
 ;;=H04.201^^130^1292^28
 ;;^UTILITY(U,$J,358.3,26549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26549,1,3,0)
 ;;=3^Epiphora,Right Lacrimal Gland,Unspec
 ;;^UTILITY(U,$J,358.3,26549,1,4,0)
 ;;=4^H04.201
 ;;^UTILITY(U,$J,358.3,26549,2)
 ;;=^5004484
 ;;^UTILITY(U,$J,358.3,26550,0)
 ;;=H04.203^^130^1292^26
 ;;^UTILITY(U,$J,358.3,26550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26550,1,3,0)
 ;;=3^Epiphora,Bilateral Lacrimal Glands,Unspec
 ;;^UTILITY(U,$J,358.3,26550,1,4,0)
 ;;=4^H04.203
 ;;^UTILITY(U,$J,358.3,26550,2)
 ;;=^5004486
 ;;^UTILITY(U,$J,358.3,26551,0)
 ;;=H04.202^^130^1292^27
 ;;^UTILITY(U,$J,358.3,26551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26551,1,3,0)
 ;;=3^Epiphora,Left Lacrimal Gland,Unspec
 ;;^UTILITY(U,$J,358.3,26551,1,4,0)
 ;;=4^H04.202
 ;;^UTILITY(U,$J,358.3,26551,2)
 ;;=^5004485
 ;;^UTILITY(U,$J,358.3,26552,0)
 ;;=L72.0^^130^1292^25
 ;;^UTILITY(U,$J,358.3,26552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26552,1,3,0)
 ;;=3^Epidermal Cyst
 ;;^UTILITY(U,$J,358.3,26552,1,4,0)
 ;;=4^L72.0
 ;;^UTILITY(U,$J,358.3,26552,2)
 ;;=^5009277
 ;;^UTILITY(U,$J,358.3,26553,0)
 ;;=L72.11^^130^1292^35
 ;;^UTILITY(U,$J,358.3,26553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26553,1,3,0)
 ;;=3^Pilar Cyst
 ;;^UTILITY(U,$J,358.3,26553,1,4,0)
 ;;=4^L72.11
 ;;^UTILITY(U,$J,358.3,26553,2)
 ;;=^5009278
 ;;^UTILITY(U,$J,358.3,26554,0)
 ;;=L72.12^^130^1292^43
 ;;^UTILITY(U,$J,358.3,26554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26554,1,3,0)
 ;;=3^Trichodermal Cyst
 ;;^UTILITY(U,$J,358.3,26554,1,4,0)
 ;;=4^L72.12
 ;;^UTILITY(U,$J,358.3,26554,2)
 ;;=^5009279
 ;;^UTILITY(U,$J,358.3,26555,0)
 ;;=L72.8^^130^1292^29
 ;;^UTILITY(U,$J,358.3,26555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26555,1,3,0)
 ;;=3^Follicular Cysts of Skin/Subcutaneous Tissue NEC
 ;;^UTILITY(U,$J,358.3,26555,1,4,0)
 ;;=4^L72.8
 ;;^UTILITY(U,$J,358.3,26555,2)
 ;;=^5009282
 ;;^UTILITY(U,$J,358.3,26556,0)
 ;;=H35.31^^130^1293^19
 ;;^UTILITY(U,$J,358.3,26556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26556,1,3,0)
 ;;=3^Nonexudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,26556,1,4,0)
 ;;=4^H35.31
 ;;^UTILITY(U,$J,358.3,26556,2)
 ;;=^5005647
 ;;^UTILITY(U,$J,358.3,26557,0)
 ;;=H35.32^^130^1293^10
 ;;^UTILITY(U,$J,358.3,26557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26557,1,3,0)
 ;;=3^Exudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,26557,1,4,0)
 ;;=4^H35.32
 ;;^UTILITY(U,$J,358.3,26557,2)
 ;;=^5005648
 ;;^UTILITY(U,$J,358.3,26558,0)
 ;;=H35.352^^130^1293^2
 ;;^UTILITY(U,$J,358.3,26558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26558,1,3,0)
 ;;=3^Cystoid Macular Degeneration,Left Eye
